[
  {
    "ts": "2026-02-18T02:21:20+00:00",
    "headline": "This State Has More Millionaires Per Capita Than Any Other",
    "summary": "There are many ways to describe America. Some might call it a veritable patchwork of diverse cultures and social strata. That’s a fancy way of saying that prosperity is concentrated in some U.S. states more than in others. As a result, a handful of America’s 50 states have more millionaires than others. By the process ... This State Has More Millionaires Per Capita Than Any Other",
    "url": "https://247wallst.com/investing/2026/02/17/this-state-has-more-millionaires-per-capita-than-any-other/",
    "source": "24/7 Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "c78046f0-1ca5-32dc-85cf-6f8c38a5db54",
      "content": {
        "id": "c78046f0-1ca5-32dc-85cf-6f8c38a5db54",
        "contentType": "STORY",
        "title": "This State Has More Millionaires Per Capita Than Any Other",
        "description": "",
        "summary": "There are many ways to describe America. Some might call it a veritable patchwork of diverse cultures and social strata. That’s a fancy way of saying that prosperity is concentrated in some U.S. states more than in others. As a result, a handful of America’s 50 states have more millionaires than others. By the process ... This State Has More Millionaires Per Capita Than Any Other",
        "pubDate": "2026-02-18T02:21:20Z",
        "displayTime": "2026-02-18T02:21:20Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/24_7_wall_st__718/f7109cc114790579cb27b509e454b2fa",
          "originalWidth": 2560,
          "originalHeight": 1707,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/BsdaEb1kKl4fYOmiuFHAbQ--~B/aD0xNzA3O3c9MjU2MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/24_7_wall_st__718/f7109cc114790579cb27b509e454b2fa.cf.webp",
              "width": 2560,
              "height": 1707,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.yBu0G0aPHwBbKcaFQSnrA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/24_7_wall_st__718/f7109cc114790579cb27b509e454b2fa.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "24/7 Wall St.",
          "url": "https://247wallst.com/"
        },
        "canonicalUrl": {
          "url": "https://247wallst.com/investing/2026/02/17/this-state-has-more-millionaires-per-capita-than-any-other/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/state-more-millionaires-per-capita-022120447.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-18T15:10:00+00:00",
    "headline": "Evinova Announces Strategic Collaborations with Astellas, AstraZeneca and Bristol Myers Squibb Advancing Its AI-Native Platform to Accelerate Global Clinical Development",
    "summary": "BAAR, Switzerland, February 18, 2026--Evinova announces strategic collaborations with Astellas, AstraZeneca and Bristol Myers Squibb advancing its AI-native platform",
    "url": "https://finance.yahoo.com/news/evinova-announces-strategic-collaborations-astellas-151000480.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "2b04315d-aaed-39c5-9db3-b46caf0804a8",
      "content": {
        "id": "2b04315d-aaed-39c5-9db3-b46caf0804a8",
        "contentType": "STORY",
        "title": "Evinova Announces Strategic Collaborations with Astellas, AstraZeneca and Bristol Myers Squibb Advancing Its AI-Native Platform to Accelerate Global Clinical Development",
        "description": "",
        "summary": "BAAR, Switzerland, February 18, 2026--Evinova announces strategic collaborations with Astellas, AstraZeneca and Bristol Myers Squibb advancing its AI-native platform",
        "pubDate": "2026-02-18T15:10:00Z",
        "displayTime": "2026-02-18T15:10:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/5f118fc86a1a47e7b4545a467fe63088",
          "originalWidth": 1024,
          "originalHeight": 512,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4eZMnIgh6J4xL.WHwI1X.A--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/5f118fc86a1a47e7b4545a467fe63088.cf.webp",
              "width": 1024,
              "height": 512,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QKXWcLOaOSE8DsUINpc8rQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/5f118fc86a1a47e7b4545a467fe63088.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/evinova-announces-strategic-collaborations-astellas-151000480.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/evinova-announces-strategic-collaborations-astellas-151000480.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ALPMF"
            },
            {
              "symbol": "AZN"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-18T15:01:53+00:00",
    "headline": "BioArctic AB (BRCTF) Q4 2025 Earnings Call Highlights: Record Growth and Strategic Partnerships ...",
    "summary": "BioArctic AB (BRCTF) reports a transformative year with significant financial growth, new project expansions, and successful global partnerships, despite challenges in European markets.",
    "url": "https://finance.yahoo.com/news/bioarctic-ab-brctf-q4-2025-150153255.html",
    "source": "GuruFocus.com",
    "provider": "yfinance",
    "raw": {
      "id": "bde452c1-681a-36d6-991b-5e829f4f16b3",
      "content": {
        "id": "bde452c1-681a-36d6-991b-5e829f4f16b3",
        "contentType": "STORY",
        "title": "BioArctic AB (BRCTF) Q4 2025 Earnings Call Highlights: Record Growth and Strategic Partnerships ...",
        "description": "",
        "summary": "BioArctic AB (BRCTF) reports a transformative year with significant financial growth, new project expansions, and successful global partnerships, despite challenges in European markets.",
        "pubDate": "2026-02-18T15:01:53Z",
        "displayTime": "2026-02-18T15:01:53Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "GuruFocus.com",
          "url": "http://www.gurufocus.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bioarctic-ab-brctf-q4-2025-150153255.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bioarctic-ab-brctf-q4-2025-150153255.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BRCTF"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "NVS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-18T10:35:17+00:00",
    "headline": "FDA accepts BMS protein degrader for review; Disc rare disease drug rejected",
    "summary": "Cytokinetics’ heart disease drug secured European approval. Elsewhere, Teva and Sanofi reported longer-term data from an experimental therapy targeting ulcerative colitis and Crohn’s disease.",
    "url": "https://www.biopharmadive.com/news/disc-news-roundup-pharma-biotech/812351/",
    "source": "BioPharma Dive",
    "provider": "yfinance",
    "raw": {
      "id": "a586da5d-6381-3c51-bd69-6fa7cd7ce483",
      "content": {
        "id": "a586da5d-6381-3c51-bd69-6fa7cd7ce483",
        "contentType": "STORY",
        "title": "FDA accepts BMS protein degrader for review; Disc rare disease drug rejected",
        "description": "",
        "summary": "Cytokinetics’ heart disease drug secured European approval. Elsewhere, Teva and Sanofi reported longer-term data from an experimental therapy targeting ulcerative colitis and Crohn’s disease.",
        "pubDate": "2026-02-18T10:35:17Z",
        "displayTime": "2026-02-18T10:35:17Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/biopharma_dive_768/e36d70a3849ea73409df7aca9613c259",
          "originalWidth": 1600,
          "originalHeight": 900,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YSECyFvzK8sIEiUW4LIicA--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/biopharma_dive_768/e36d70a3849ea73409df7aca9613c259.cf.webp",
              "width": 1600,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/heEgXBvKL8Y58FXAXGaXPg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/biopharma_dive_768/e36d70a3849ea73409df7aca9613c259.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "BioPharma Dive",
          "url": "https://biopharmadive.com/"
        },
        "canonicalUrl": {
          "url": "https://www.biopharmadive.com/news/disc-news-roundup-pharma-biotech/812351/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/fda-accepts-bms-protein-degrader-103517143.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            },
            {
              "symbol": "IRON"
            },
            {
              "symbol": "CYTK"
            },
            {
              "symbol": "TEVA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-18T14:32:00+00:00",
    "headline": "Cytokinetics Wins EU Approval for Cardiovascular Drug Myqorzo",
    "summary": "CYTK secures EU approval for Myqorzo in symptomatic obstructive HCM, expanding its first commercial drug across major global markets.",
    "url": "https://finance.yahoo.com/news/cytokinetics-wins-eu-approval-cardiovascular-143200974.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "77578a20-f68d-31c8-ad62-5d177c026f58",
      "content": {
        "id": "77578a20-f68d-31c8-ad62-5d177c026f58",
        "contentType": "STORY",
        "title": "Cytokinetics Wins EU Approval for Cardiovascular Drug Myqorzo",
        "description": "",
        "summary": "CYTK secures EU approval for Myqorzo in symptomatic obstructive HCM, expanding its first commercial drug across major global markets.",
        "pubDate": "2026-02-18T14:32:00Z",
        "displayTime": "2026-02-18T14:32:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/4658663242c3a61dee3fef55a1bf4887",
          "originalWidth": 620,
          "originalHeight": 413,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rbSgl25Zi2GiiDMk0hXrSg--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4658663242c3a61dee3fef55a1bf4887.cf.webp",
              "width": 620,
              "height": 413,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/NAknAcj0fz57CxpyeoYG3A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4658663242c3a61dee3fef55a1bf4887.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/cytokinetics-wins-eu-approval-cardiovascular-143200974.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/cytokinetics-wins-eu-approval-cardiovascular-143200974.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CYTK"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-18T16:31:00+00:00",
    "headline": "FDA Accepts BMY's NDA for Iberdomide Combo in Multiple Myeloma",
    "summary": "FDA accepts and grants priority review to Bristol Myers' NDA for iberdomide combo in relapsed or refractory multiple myeloma. A decision is due on Aug. 17, 2026.",
    "url": "https://finance.yahoo.com/news/fda-accepts-bmys-nda-iberdomide-163100528.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "93db5044-b913-3c3a-9724-3f8420a1b0b7",
      "content": {
        "id": "93db5044-b913-3c3a-9724-3f8420a1b0b7",
        "contentType": "STORY",
        "title": "FDA Accepts BMY's NDA for Iberdomide Combo in Multiple Myeloma",
        "description": "",
        "summary": "FDA accepts and grants priority review to Bristol Myers' NDA for iberdomide combo in relapsed or refractory multiple myeloma. A decision is due on Aug. 17, 2026.",
        "pubDate": "2026-02-18T16:31:00Z",
        "displayTime": "2026-02-18T16:31:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/8127f43af74d394c31adc7eb2e1fa286",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/mLvYz_6QDZpmLi9HeP74BQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/8127f43af74d394c31adc7eb2e1fa286.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sCu1p_n3Uis09b9TxkQITQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/8127f43af74d394c31adc7eb2e1fa286.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/fda-accepts-bmys-nda-iberdomide-163100528.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/fda-accepts-bmys-nda-iberdomide-163100528.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]